Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

How is VOO stock faring? The Vanguard S&P 500 ETF is down 1.38% in the past five days but up 14.55% year-to-date. Fund Flows ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

Detailed price information for Sunshine Biopharma (SBFM-Q) from The Globe and Mail including charting and trades.

Recent analyst actions have put the spotlight on significant upgrades and downgrades. Among the upgrades, Broadcom ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Despite its sharp rebound, the sector remains about 40% below its pandemic peak, leaving it as one of the few areas of the ...

From Elon Musk and Satya Nadella to the co-founder of Moderna, it’s not just tycoons in Silicon Valley who have benefited ...

Indian equity markets posted slight gains in Samvat 2081, with Nifty 50 up 3.6% and Sensex 2.8% from Diwali 2024 to October ...

From Elon Musk and Satya Nadella to the co-founder of Moderna, it’s not just tycoons in Silicon Valley who have benefited from the controversial work visa now in Donald Trump’s crosshairs, writes Io D ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...